After diagnosis, the patient was admitted to the hematology/oncology service of the hospital and started immediately on induction chemotherapy (7+3 C1D1). He was regularly transfused to resolve ...

The patient was started on chemotherapy with obinutuzumab (1000 mg) and bendamustine (120 mg, i.e., 70mg/m2) on July 7, 2024 as C1D1 treatment. Notably, there were no infusion-related reactions; the ...

within the last 45 days before the first dose of [212Pb]VMT01 on C1D1. * Current abuse of alcohol or illicit drugs * Existence of any medical or social issues likely to interfere with study conductor ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...